Home › Metastatic Cancer › Vermont
Metastatic Cancer clinical trials in Vermont
4 studies for Metastatic Cancer are looking for participants at sites in Vermont.
Cities in Vermont
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- The University of Vermont Medical Center Inc., Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07174336A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Vermont Medical Center Inc., Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Vermont Medical Center, Burlington
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
- University of Vermont Medical Center, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06778408From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.